Nancy Ann Deparle

CIK: 0001144511

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

HCA

HCA Healthcare, Inc.

Director

CVS

CVS HEALTH Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

HCA
HCA Healthcare, Inc.
Apr 28, 2026
Award(A)
Direct
509 shares-
HCA
HCA Healthcare, Inc.
Apr 29, 2025
Award(A)
Direct
645 shares-
CVS
CVS HEALTH Corp
Nov 21, 2024
Award(A)
Direct
2.3K shares at avg. $57.10$133K

		Type	Shares	Price		Ownership
Apr 28, 2026	HCA HCA Healthcare, Inc.	Award(A)	509	-	$0	Direct
Apr 29, 2025	HCA HCA Healthcare, Inc.	Award(A)	645	-	-	Direct
Nov 21, 2024	CVS CVS HEALTH Corp	Award(A)	2,331	$57.10	$133,100	Direct

1-3 of 3 transactions

About DEPARLE NANCY ANN

DEPARLE NANCY ANN (SEC CIK 0001144511) files insider reports with the SEC as Director of HCA Healthcare, Inc. (HCA) and Director of CVS HEALTH Corp (CVS).

Signal8 holds 3 ownership filings by DEPARLE NANCY ANN, all Form 4s, filed between Nov 25, 2024 and Apr 30, 2026. Those filings report 3 transactions, from Nov 21, 2024 to Apr 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DEPARLE NANCY ANN's filings is in NASHVILLE, TN.

Recent filings by DEPARLE NANCY ANN

Apr 28, 2026: Grant or award of HCA shares (Form 4, code A).
Apr 29, 2025: Grant or award of HCA shares (Form 4, code A).
Nov 21, 2024: Grant or award of CVS shares (Form 4, code A).

Other insiders filing for HCA Healthcare, Inc. (HCA)

Marks Mike A, EVP and CFO
Schlosser Michael J, EVP and Chief Clinical Officer
McAlevey Michael R, EVP & Chief Legal & Admin Off.
Frist William R, Director
FRIST THOMAS F III, Director
Smith Andrea B, Director

How to read Form 4 transaction codes